158 related articles for article (PubMed ID: 1831839)
1. Technetium-99m-MAG3 clearance as a parameter of effective renal plasma flow in patients with proteinuria and lowered serum albumin levels.
Kengen RA; Meijer S; Beekhuis H; Piers DA
J Nucl Med; 1991 Sep; 32(9):1709-12. PubMed ID: 1831839
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-MAG3 versus 131I-orthoiodohippurate in the routine determination of effective renal plasma flow.
Bagni B; Portaluppi F; Montanari L; Prandini N; Zatta G
J Nucl Med Allied Sci; 1990; 34(2):67-70. PubMed ID: 2147211
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of renal scintigraphy and clearance with 99mTc-MAG3 and 123I-hippurate in patients with renal disorders.
Müller-Suur R; Bois-Svensson I; Mesko L
Contrib Nephrol; 1990; 79():32-5. PubMed ID: 2146087
[No Abstract] [Full Text] [Related]
4. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-MAG3: dynamic studies in patients with renal disease.
Schaap GH; Alferink TH; de Jong RB; Oe PL; Roos JC; Donker AJ
Eur J Nucl Med; 1988; 14(1):28-31. PubMed ID: 2968259
[TBL] [Abstract][Full Text] [Related]
6. Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance.
Taylor A; Corrigan P; Eshima D; Folks R
J Nucl Med; 1992 Sep; 33(9):1620-2. PubMed ID: 1387682
[TBL] [Abstract][Full Text] [Related]
7. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
[TBL] [Abstract][Full Text] [Related]
8. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
Coveney JR; Robbins MS
J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
[TBL] [Abstract][Full Text] [Related]
9. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of technetium-99m-MAG3 in humans.
Bubeck B; Brandau W; Weber E; Kälble T; Parekh N; Georgi P
J Nucl Med; 1990 Aug; 31(8):1285-93. PubMed ID: 2143528
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of renal scintigraphy and clearance with technetium-99m-MAG3 and iodine-123-hippurate in patients with renal disorders.
Müller-Suur R; Bois-Svensson I; Mesko L
J Nucl Med; 1990 Nov; 31(11):1811-7. PubMed ID: 2146371
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.
Jafri RA; Britton KE; Nimmon CC; Solanki K; Al-Nahhas A; Bomanji J; Fettich J; Hawkins LA
J Nucl Med; 1988 Feb; 29(2):147-58. PubMed ID: 2964516
[TBL] [Abstract][Full Text] [Related]
13. Estimation of technetium 99m mercaptoacetyltriglycine plasma clearance by use of one single plasma sample.
Müller-Suur R; Magnusson G; Bois-Svensson I; Jansson B
Eur J Nucl Med; 1991; 18(1):28-31. PubMed ID: 1826882
[TBL] [Abstract][Full Text] [Related]
14. [The estimation of effective renal plasma flow (ERPF) based on two compartment analysis using 99mTc-mercaptoacetyltriglycine (99mTc-MAG3)].
Ha-Kawa SK; Suga Y; Satou H; Tanaka Y
Kaku Igaku; 1994 Feb; 31(2):175-81. PubMed ID: 8121073
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF).
Abdel-Dayem HM; Sadek S; al-Bahar R; Sabha M; el-Sayed M
Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236
[TBL] [Abstract][Full Text] [Related]
16. Prediction of renal transplant survival from early postoperative radioisotope studies.
Russell CD; Yang H; Gaston RS; Hudson SL; Diethelm AG; Dubovsky EV
J Nucl Med; 2000 Aug; 41(8):1332-6. PubMed ID: 10945523
[TBL] [Abstract][Full Text] [Related]
17. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
Taylor A; Eshima D
J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
[TBL] [Abstract][Full Text] [Related]
18. Preliminary results comparing OIH, 99mTc-MAG3 and iothalamate in a rat model of renal ischemia.
Eshima D; Greene J; Taylor A
Contrib Nephrol; 1990; 79():24-7. PubMed ID: 2146085
[No Abstract] [Full Text] [Related]
19. Preliminary results comparing the extraction efficiencies of 131I-OIH and 99mTc-MAG3 in rat models of ischemia, renal artery stenosis, and ciclosporin toxicity.
Taylor A; Greene J; Eshima D; Dillehay D
Contrib Nephrol; 1990; 79():21-3. PubMed ID: 2146084
[No Abstract] [Full Text] [Related]
20. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
